120 related articles for article (PubMed ID: 21087818)
21. De novo CpG island methylation in human cancer cells.
Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
[TBL] [Abstract][Full Text] [Related]
22. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
23. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
[TBL] [Abstract][Full Text] [Related]
24. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
25. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression.
Piyathilake CJ; Frost AR; Bell WC; Oelschlager D; Weiss H; Johanning GL; Niveleau A; Heimburger DC; Grizzle WE
Hum Pathol; 2001 Aug; 32(8):856-62. PubMed ID: 11521231
[TBL] [Abstract][Full Text] [Related]
26. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
27. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
28. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
[TBL] [Abstract][Full Text] [Related]
29. Alterations of DNA methylation and clinicopathological diversity of human cancers.
Kanai Y
Pathol Int; 2008 Sep; 58(9):544-58. PubMed ID: 18801069
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
[TBL] [Abstract][Full Text] [Related]
31. Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells.
Lin RK; Hsu CH; Wang YC
Anticancer Drugs; 2007 Nov; 18(10):1157-64. PubMed ID: 17893516
[TBL] [Abstract][Full Text] [Related]
32. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
33. Aberrant promoter hypermethylation in biliary tract carcinoma.
Kohya N; Koga Y; Kitajima Y; Miyazaki K
J Hepatobiliary Pancreat Surg; 2006; 13(4):296-305. PubMed ID: 16858540
[TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
[TBL] [Abstract][Full Text] [Related]
35. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
36. An essential role for DNA methyltransferase 3a in melanoma tumorigenesis.
Deng T; Kuang Y; Wang L; Li J; Wang Z; Fei J
Biochem Biophys Res Commun; 2009 Sep; 387(3):611-6. PubMed ID: 19632198
[TBL] [Abstract][Full Text] [Related]
37. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
Park HJ; Yu E; Shim YH
Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
39. Stalling of DNA methyltransferase in chromosome stability and chromosome remodelling (Review).
Smith SS
Int J Mol Med; 1998 Jan; 1(1):147-56. PubMed ID: 9852213
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]